How many clinical trials are there for Transformed Splenic Marginal Zone Lymphoma?

PlainTrial tracks 1 US clinical trials for Transformed Splenic Marginal Zone Lymphoma, of which 1 are currently recruiting.

How do I find a recruiting trial for Transformed Splenic Marginal Zone Lymphoma?

Use the trial list filtered by Recruiting status, or visit the trial finder to search by condition and state. Always discuss with your healthcare provider.

Is this data current?

Data is from ClinicalTrials.gov. Trial status may have changed. Always verify at ClinicalTrials.gov before making participation decisions.

Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

Transformed Splenic Marginal Zone Lymphoma clinical trials

Compiled by PlainTrial · August 8, 2026

1 of 1 indexed Transformed Splenic Marginal Zone Lymphoma trials are currently recruiting.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Transformed Splenic Marginal Zone Lymphoma: 1 US clinical trial tracked, 1 recruiting.

Transformed Splenic Marginal Zone Lymphoma is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is International Extranodal Lymphoma Study Group (IELSG), running 1 of these trials.

Enrollment posture brief

Registry condition transformed-splenic-marginal-zone-lymphoma

Volume-matched condition peers

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Open-enrollment share among volume-matched conditions near Transformed Splenic Marginal Zone Lymphoma

Transformed Splenic Marginal Zone Lymphoma lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Transformed Splenic Marginal Zone Lymphoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

Transformed Splenic Marginal Zone Lymphoma is recruiting above its size-band peers.

1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Open and recent trials

1 total, page 1 of 1

RECRUITING 100 participants

Integrated Molecular and Clinical Profiling of Transformed Splenic Marginal Zone Lymphoma

International Extranodal Lymphoma Study Group (IELSG)

NCT06712459

Phase Distribution

Phase data not available

Top Sponsors

International Extranodal Lymphoma Study Group (IELSG) 1 trials

US sites by state

Facility locations filed on Transformed Splenic Marginal Zone Lymphoma trials. A trial with sites in several states counts in each.

New York 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Transformed Splenic Marginal Zone Lymphoma page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

1 Transformed Splenic Marginal Zone Lymphoma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
International Extranodal Lymphoma Study Group (IELSG) sponsors the most Transformed Splenic Marginal Zone Lymphoma trials on record, review their full trial history before evaluating a specific study. See International Extranodal Lymphoma Study Group (IELSG)'s trials
Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Transformed Splenic Marginal Zone Lymphoma condition card totals 1 registered trials; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.